Materials and methods involving hybrid vascular endothelial growth factor DNAs and proteins

Kari Kustaa Alitalo; Michael Jeltsch

Materials and methods involving hybrid vascular endothelial growth factor DNAs and proteins

Tutkimusohjelmayksikkö

Tutkimustuotos: Patentti

Abstrakti

The present invention provides polypeptides that bind cellular receptors for vascular endothelial growth factor polypeptides; polynucleotides encoding such polypeptides; compositions comprising the polypeptides and polynucleotides; and methods and uses involving the foregoing. Some polypeptides of the invention exhibit unique receptor binding profiles compared to known, naturally occurring vascular endothelial growth factors.

Alkuperäiskieli	englanti
Julkaisuvuosi	2 lokak. 2012
Tila	Julkaistu - 2 lokak. 2012
OKM-julkaisutyyppi	H1 Myönnetyt patentit

Pääsy asiakirjaan

Materials and methods involving hybrid vascular endothelial growth factor DNAs and proteins

http://patft1.uspto.gov/netacgi/nph-Parser?patentnumber=8278098

Siteeraa tätä

@misc{a8b88166acef42729c22414f57a33a19,

title = "Materials and methods involving hybrid vascular endothelial growth factor DNAs and proteins",

abstract = "The present invention provides polypeptides that bind cellular receptors for vascular endothelial growth factor polypeptides; polynucleotides encoding such polypeptides; compositions comprising the polypeptides and polynucleotides; and methods and uses involving the foregoing. Some polypeptides of the invention exhibit unique receptor binding profiles compared to known, naturally occurring vascular endothelial growth factors.",

author = "Alitalo, {Kari Kustaa} and Michael Jeltsch",

year = "2012",

month = oct,

day = "2",

language = "English",

publisher = "US Patent and Trademark Office",

address = "United States",

type = "Patent",

note = "US 8,278,098 B2",

}

TY - PAT

T1 - Materials and methods involving hybrid vascular endothelial growth factor DNAs and proteins

AU - Alitalo, Kari Kustaa

AU - Jeltsch, Michael

PY - 2012/10/2

Y1 - 2012/10/2

N2 - The present invention provides polypeptides that bind cellular receptors for vascular endothelial growth factor polypeptides; polynucleotides encoding such polypeptides; compositions comprising the polypeptides and polynucleotides; and methods and uses involving the foregoing. Some polypeptides of the invention exhibit unique receptor binding profiles compared to known, naturally occurring vascular endothelial growth factors.

AB - The present invention provides polypeptides that bind cellular receptors for vascular endothelial growth factor polypeptides; polynucleotides encoding such polypeptides; compositions comprising the polypeptides and polynucleotides; and methods and uses involving the foregoing. Some polypeptides of the invention exhibit unique receptor binding profiles compared to known, naturally occurring vascular endothelial growth factors.

M3 - Patent

M1 - US 8,278,098 B2

Y2 - 2012/10/02

PB - US Patent and Trademark Office

ER -